Skip to main content
See every side of every news story
Published loading...Updated

Health Check: Polynovo shares go crackers after positive US reimbursement changes

Summary by Stockhead
Perversely, Polynovo stands to benefit from a US reimbursement cut for outpatients ASX biotechs had a poor August, but they will Spring into action Race Oncology opens Hong Kong site in “cautious” trial rollout   PolyNovo (ASX:PNV) shares have sprung to a perky Spring start, soaring up to 25% on news of a favourable US reimbursement change for outpatient wound care procedures. Glad to hear that someone’s happy with the RFK Junior regime! As Poly…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

sharecafe.com.au broke the news in on Tuesday, September 2, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal